ConductScience.org, home

Paper175653

Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.

Olefsky JM and 1 other. Am J Med, 1976. Cited by 245 papers, by iCite.

Cite this record

ConductScience Library. Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Papers, record 175653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/175653

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.
PubMed
Journal
Am J Med
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
245
iCite
Relative citation ratio, by iCite
10.2
iCite
Revised in PubMed
2019-06-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Olefsky JMJ M
2Reaven GMG M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChlorpropamideMajor topic
Diabetes MellitusMajor topic
InsulinMajor topic
MonocytesMajor topic
Receptors, Cell SurfaceMajor topic
Adult
Female
Humans
Hyperglycemia
Insulin Resistance
Male
Middle Aged
Protein Binding

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 245 citations.

PMIDTitleJournalYearIn PapersSource
26322096Sulfonylureas and their use in clinical practice.Arch Med Sci2015https://conductscience.org/library/papers/26322096PubMed
18376071Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes.J Biosci2008https://conductscience.org/library/papers/18376071PubMed
7047270Insulin responsiveness of superficial forearm tissues in type 2 (non-insulin dependent) diabetes.Diabetologia1982https://conductscience.org/library/papers/7047270PubMed
7030708Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.Drugs1981https://conductscience.org/library/papers/7030708PubMed
7019248In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.J Clin Invest1981https://conductscience.org/library/papers/7019248PubMed
7009650Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.J Clin Invest1981https://conductscience.org/library/papers/7009650PubMed
7008780Insulin action and binding in isolated hepatocytes from fasted, streptozotocin-diabetic, and older, spontaneously obese rats.Biochem J1980https://conductscience.org/library/papers/7008780PubMed
6988265Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.Diabetologia1980https://conductscience.org/library/papers/6988265PubMed
6772676Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.J Clin Invest1980https://conductscience.org/library/papers/6772676PubMed
6434794Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.Klin Wochenschr1984https://conductscience.org/library/papers/6434794PubMed
6403102Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6403102PubMed
6381193Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture.Diabetologia1984https://conductscience.org/library/papers/6381193PubMed
6378583Oral hypoglycaemic agents. An update.Drugs1984https://conductscience.org/library/papers/6378583PubMed
6350080Sulphonylureas in vitro do not alter insulin binding or insulin effect on amino acid transport in rat hepatocytes.Diabetologia1983https://conductscience.org/library/papers/6350080PubMed
6147291Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.Diabetologia1984https://conductscience.org/library/papers/6147291PubMed
3936738Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.Diabetologia1985https://conductscience.org/library/papers/3936738PubMed
3933984Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3933984PubMed
3552593The insulin receptor concept and its relation to the treatment of diabetes.Drugs1987https://conductscience.org/library/papers/3552593PubMed
3322906Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas.Diabetologia1987https://conductscience.org/library/papers/3322906PubMed
3149105Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy.Acta Diabetol Lat1988https://conductscience.org/library/papers/3149105PubMed

See all 30 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
INSR3643PubTator's text mininghttps://conductscience.org/library/genes/3643NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/175653

GET https://conductscience.org/api/papers/v1/175653/cited_by?page=2